ANCA-Associated Vasculitis following the First Dose of Pfizer-BioNTech COVID-19 Vaccine
Georges El Hasbani, Imad Uthman
Abstract
Coronavirus disease (COVID-19) vaccine can alter the body's immunological balance leading to autoimmune disease in rare cases. Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is one of the autoimmune diseases which have been rarely reported to appear post-COVID-19 vaccine. Herein, we report the case of a 47-year-old woman who developed acute renal failure few days after receiving the first dose of the Pfizer-BioNTech COVID-19 vaccine. Corticosteroids along with azathioprine were used for the management.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Vasculitis2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DermatologyInternal medicinePathologyOutbreakDiseaseInfectious disease (medical specialty)Vasculitis and related conditionsHeparin-Induced Thrombocytopenia and ThrombosisDrug-Induced Adverse Reactions